Oxford Cannabinoid Technologies (LON:OCTP) Stock Price Down 4.2% – Should You Sell?

Oxford Cannabinoid Technologies Holdings Plc (LON:OCTPGet Free Report) shares were down 4.2% during mid-day trading on Thursday . The company traded as low as GBX 0.12 ($0.00) and last traded at GBX 0.12 ($0.00). Approximately 11,402,242 shares were traded during trading, an increase of 22% from the average daily volume of 9,326,041 shares. The stock had previously closed at GBX 0.12 ($0.00).

Oxford Cannabinoid Technologies Price Performance

The company has a fifty day moving average price of GBX 0.12 and a 200 day moving average price of GBX 0.20. The company has a market cap of £1.25 million, a PE ratio of -53.10 and a beta of 0.82.

About Oxford Cannabinoid Technologies

(Get Free Report)

Oxford Cannabinoid Technologies Holdings Plc, a pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based prescription medicines. Its lead drug candidate consists of OCT461201, an CB2 receptor, that is in phase I clinical trial for use in the treatment of chemotherapy-induced peripheral neuropathy and irritable bowel syndrome (IBS), as well as in neuropathic and visceral pain conditions.

Further Reading

Receive News & Ratings for Oxford Cannabinoid Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Cannabinoid Technologies and related companies with MarketBeat.com's FREE daily email newsletter.